{"id":"W2118058941","doi":"10.1111/j.1365-4632.2007.03158.x","title":"Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open‐label, multicenter, Phase IIIb study","year":2007,"lang":"en","type":"article","venue":"International Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Genentech; Abbott Laboratories","keywords":"Medicine; Efalizumab; Dermatology; Psoriasis; Multicenter study; Open label; Plaque psoriasis; Clinical trial; Surgery; Internal medicine; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007223727,0.0007024532,0.001551971,0.0002060732,0.0004625134,0.001182892,0.0006386132,0.001205957,0.001899815],"category_scores_gemma":[0.0043849,0.000407798,0.001610171,0.0003597348,0.0009173673,0.001034142,0.0002881849,0.003333162,0.0004307109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000620205,"about_ca_system_score_gemma":0.001319816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005581181,"about_ca_topic_score_gemma":0.0009375401,"domain_scores_codex":[0.9978995,0.001344514,0.0001562056,0.0001993437,0.000213898,0.0001864727],"domain_scores_gemma":[0.9948896,0.002025996,0.001060499,0.0005027337,0.0003106148,0.001210491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7133678,0.08876434,0.02055427,0.0009454525,0.002825115,0.0002183371,0.0006108618,0.001137712,0.02710551,0.0001805045,0.003811284,0.1404788],"study_design_scores_gemma":[0.5919,0.3608042,0.0393905,0.0001123751,0.001213118,0.0003641976,0.0001268253,0.0009619718,0.002487871,0.0001217475,0.002469362,0.00004775871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952431,0.002396438,0.000404722,0.0004154379,0.00008572562,0.0005667512,0.0003216969,0.00002988307,0.0005361312],"genre_scores_gemma":[0.9941065,0.00141662,0.00119673,0.001021868,0.0001841001,0.0008340109,0.0008882752,0.00001773464,0.0003341503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007223727,"threshold_uncertainty_score":0.03820318,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03201650071560092,"score_gpt":0.3476767070902343,"score_spread":0.3156602063746334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}